TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 2 | 1 | 14 | 112 | 29 | 0 | 32 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/13/21 20:41 | 12/9/21 | AGLE | Aeglea Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shanafelt Armen | TX | D | P.m | 550 | 3.66 | 0 | 150 | New | 150 | D | |||||||||||||||
4/23/18 16:16 | 4/23/18 | SURF | Surface Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Shanafelt Armen | IN | DT | P.d | 3,990 | 15.00 | 0 | 266 | 8 | 3,448 | I | |||||||||||||||
7/7/17 19:18 | 7/5/17 | ALRN | Aileron Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Shanafelt Armen | IN | D | P.d | 3,750 | 15.00 | 0 | 250 | 30 | 1,095 | I | |||||||||||||||
8/16/16 18:20 | 8/16/16 | PTGX | Protagonist Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Shanafelt Armen | IN | DT | P.d | 7,000 | 12.00 | 1 | 583 | 38 | 2,099 | I | 2 | 1 | 14 | 112 | 29 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |